Literature DB >> 292827

Poor outlook for childhood acute lymphoblastic leukaemia with relapse.

H Ekert, W M Ellis, K D Waters, R N Matthews.   

Abstract

Results of treatment in 72 children with a relapse of acute lymphoblastic leukaemia were analysed. A second remission was induced in 57 children (79%). Remission rates were significantly higher in males, and in patients with white cell counts less than 30 X 10(9)/L. The median duration of the second remission was only four months, and the median duration of survival from the time of relapse was nine months. The median duration of survival from the time of diagnosis was 27 months. Among children who suffered a relapse was a small group who had prolonged survival and prolonged second remissions. It is uncertain whether some of these may have a chance of "cure".

Entities:  

Mesh:

Year:  1979        PMID: 292827     DOI: 10.5694/j.1326-5377.1979.tb127098.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

1.  VM26 therapy in children with drug-refractory lymphocytic leukemia.

Authors:  G Rivera; G V Dahl; S B Murphy; W P Bowman; R J Aur; T L Avery; J V Simone
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Current management of childhood acute lymphocytic leukemia.

Authors:  H Ekert
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

3.  Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia.

Authors:  G Henze; R Fengler; R Hartmann; R Dopfer; U Göbel; N Graf; H Jürgens; D Niethammer; J Ritter; G Schellong
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Late marrow recurrences in childhood acute lymphoblastic leukaemia.

Authors:  J M Chessells; F Breatnach
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.